Modified DEP Regimens for the Treatment of Hemophagocytic Lymphohistiocytosis
NCT06504030
·
clinicaltrials.gov ↗
PHASE4
Phase
NOT_YET_RECRUITING
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Hemophagocytic Lymphohistiocytoses
Interventions
DRUG:
modified-DEP
Sponsor
The First Affiliated Hospital of Soochow University